NCCN Publishes New Patient Resource for Stage 0 Breast Cancer
New NCCN Guidelines for Patients®: Stage 0 Breast Cancer is now available free-of-charge on NCCN.org/patients; NCCN Guidelines for Patients® are educational resources that offer patient-friendly treatment information
FORT WASHINGTON, PA — The National Comprehensive Cancer Network® (NCCN®), with the support of the NCCN Foundation®, announces the availability of NCCN Guidelines for Patients®: Stage 0 Breast Cancer—the latest addition to the library of NCCN Guidelines for Patients® available free-of-charge at NCCN.org/patients. This is the first stage-specific NCCN Guidelines for Patients published by NCCN.
The NCCN Guidelines for Patients, patient-friendly translations of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), are designed to provide people with cancer and their caregivers with state-of-the-art treatment information in easy-to-understand language.
This is the first installment of a complete library of NCCN Guidelines for Patients®: Breast Cancer, broken out by cancer stage. Subsequent stages for breast cancer are expected to publish in 2014. NCCN Guidelines for Patients®: Breast Cancer, Version 2.2011, which covers treatment options for all stages of breast cancer, will remain available on NCCN.org/patients until all other installments of stage-specific treatment information are published for the disease type.
“In the past years, there have been tremendous research and treatment developments in the field of breast cancer,” said Robert W. Carlson, MD, Chief Executive Officer, NCCN. “Therefore, patients can be overwhelmed by the amount of information available. By breaking down this patient resource by stage and making world-class treatment explanations even more accessible, NCCN further empowers patients to make well-informed decisions about their treatment.”
The NCCN Guidelines® are developed by multidisciplinary panels of experts from NCCN Member Institutions and feature sequential decision outlines that address appropriate management options from initial work-up throughout the course of the disease. The NCCN Guidelines for Patients translate the professional Guidelines in a clear, step-by-step manner that people can use as the basis for making decisions and discussing treatment options with their physicians.
In addition to the patient resources for breast cancer, NCCN currently offers 12 additional NCCN Guidelines for Patients, including Colon, Esophageal, Non-Small Cell Lung, Ovarian, Pancreatic, and Prostate Cancers, Caring for Adolescents and Young Adults (AYA), Chronic Myelogenous Leukemia, Malignant Pleural Mesothelioma, Melanoma, Multiple Myeloma, and Lung Cancer Screening. NCCN Guidelines for Patients are made possible by charitable donations to the NCCN Foundation. Print versions are available for certain disease types. Visit NCCN.org/patients to request free copies.
###
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 23 of the world’s leading cancer centers devoted to patient care, research, and education, is dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers.
The NCCN Member Institutions are: Fred and Pamela Buffett Cancer Center at The Nebraska Medical Center, Omaha, NE; City of Hope Comprehensive Cancer Center, Los Angeles, CA; Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center, Boston, MA; Duke Cancer Institute, Durham, NC; Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Memorial Sloan-Kettering Cancer Center, New York, NY; Moffitt Cancer Center, Tampa, FL; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH; Roswell Park Cancer Institute, Buffalo, NY; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO; St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center, Memphis, TN; Stanford Cancer Institute, Stanford, CA; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; UC San Diego Moores Cancer Center, La Jolla, CA; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of Colorado Cancer Center, Aurora, CO; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; The University of Texas MD Anderson Cancer Center, Houston, TX; and Vanderbilt-Ingram Cancer Center, Nashville, TN.
Clinicians, visit NCCN.org. Patients and caregivers, visit NCCN.org/patients.
Katie Kiley Brown, NCCN
215.690.0238
Tags: